ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631356 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631356; 2) Community: the network communities that were significantly associated with the response to NSC 631356; 3) Molecule: the relationships between components within communities and NSC 631356; 4) MDR: the compounds that were significantly associated with the NSC 631356.

NSC Compound Enrichment Correlation
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0222343516878698 0.27227943
NSC 610458 Camptothecin Derivative 0.0222343516878698 0.0084687452
NSC 621335 Null 0.0222343516878698 0.30735351
NSC 621336 Null 0.0222343516878698 0.45313934
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0222343516878698 0.51663609
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0244632509325736 -0.27553005
NSC 142475 Null 0.0244632509325736 0.26475801
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0244632509325736 -0.094556852
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0244632509325736 0.63467898
NSC 180973 Tamoxifen citrate 0.0244632509325736 0.27774104
Total:128  Current:75    [First] [Prev] [Next] [Last]